Most active investors · Jan 1, 2026 – Oct 27, 2026
Ranked by rounds participated in, from announcements in Jan 1, 2026 – Oct 27, 2026. Lead counts include only confirmed lead roles.
Browse by month
Details
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
WINN.AI $18M Series AVisitt $22M Series BDetails
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Series C+ 1
Stoke Space Technologies $860M Series DArkero $6M Pre-SeedDetails
Details
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Morpheus Space $15M StrategicCesiumAstro $470M Series CDetails
Details
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Lawhive $60M Series BVieCure $43M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Chamber Cardio $60M Series AFunnel $80M DebtDetails
Details
New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Tomorrow.io $175M GrowthVulcanForms $220M Series DDetails
Details
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Alaffia Health $55M Series BOasys Health $4.6M Seed+Pre-SeedDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
CesiumAstro $470M Series CAheadComputing $30M Seed+Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Prenosis $20M Series AAntheia $24M Series C second closeDetails
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
AON3D Undisclosed InvestmentSkyFi $12.7M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Gyde $60M UndisclosedPrudentia Sciences $20M Series ADetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Cellares $257M Series DKinaset Therapeutics $103M Series BDetails
Details
New companies 2 · Follow-on 0
Stages: Undisclosed 2
Summize $50M UndisclosedTeamFeePay £9M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Neurophos $110M Series ASage Geosystems $97M Series BDetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Preply $150M Series DHOLYWATER $22M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Fracttal $35M UndisclosedTucuvi $20M Series ADetails
New companies 2 · Follow-on 0
Stages: Series B 2
Exciva €51M Series BKinaset Therapeutics $103M Series BDetails
New companies 2 · Follow-on 0
Stages: Series A 2
Vibrant Therapeutics $61M Series ASpiro Medical $67M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 2
Ventaris Surgical $30M Series AAirNexis Therapeutics $200M Series ADetails
Details
Details
“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.